Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuterol and Caffeine for Adolescent Obesity
NCT02740660Completed
- Sponsor
- Pennington Biomedical Research Center
- Start
- Apr 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in obesity comparing Caffeine 100mg / Albuterol 4mg with Placebo (2 arms). Primary endpoints: Change in Fat Mass With Caffeine/Albuterol at 8 weeks, Change in Lean Mass With Caffeine/Albuterol at 8 weeks and 1 more. Started Apr 2016; status: completed.
02
Drugs
salbutamolcaffeine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02740660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02740660.